Asian Flush: ALDH2 Enzyme Deficiency
Asian flush is caused by a deficiency in aldehyde dehydrogenase 2 (ALDH2), specifically the ALDH2*2 variant (rs671, G>A, E487K mutation), which results in an inactive or severely reduced-activity form of this mitochondrial enzyme. 1
Biochemical Mechanism
ALDH2 is the key enzyme responsible for converting acetaldehyde (a toxic byproduct of alcohol metabolism) into nontoxic acetic acid 1. When individuals carry the ALDH2*2 variant—particularly common in East Asian populations—the enzyme has greatly reduced or absent activity, leading to systemic accumulation of acetaldehyde when alcohol is consumed 2, 3.
Clinical Presentation
The characteristic effects of ALDH2 enzyme deficiency include 1:
- Alcohol-induced facial flushing (the hallmark "Asian flush")
- Tachycardia and palpitations
- Nausea and headaches
- Reduced alcohol tolerance
These symptoms occur because accumulated acetaldehyde causes vasodilation and triggers the sympathetic nervous system 4.
Epidemiology and Genetics
This is one of the most common hereditary enzyme deficiencies worldwide, affecting 5, 6:
- 35-45% of East Asians
- 8% of the global population
- 23.5% of Asian Americans have at least one deficient ALDH2 allele
The ALDH2*2 allele produces an enzyme variant with the E487K mutation that has severely reduced enzymatic activity 2. Individuals can be:
- Heterozygotes (one deficient allele): intermediate enzyme deficiency
- Homozygotes (two deficient alleles): severe enzyme deficiency with more pronounced symptoms
Critical Health Implications
ALDH2 deficiency carries serious cancer risks that clinicians must communicate to affected patients 6:
- ALDH2 homozygotes who are moderate-to-heavy alcohol consumers have a 7-12-fold increased risk for esophageal cancer
- This makes ALDH2 deficiency the most common hereditary disorder associated with increased cancer risk
- Elevated risk extends to other aerodigestive tract cancers
- The risk is compounded by tobacco use 2
Acetaldehyde is a known carcinogen, and its accumulation in ALDH2-deficient individuals directly contributes to DNA damage and cancer development 3.
Clinical Pitfalls
Despite the aversive flushing response, many ALDH2-deficient individuals continue to drink alcohol 5:
- 61.2% of heterozygotes and 24.4% of homozygotes reported drinking in the past year
- 30.3% of heterozygotes and 16.0% of homozygotes reported binge drinking
- This paradoxical behavior dramatically increases cancer risk
Additionally, ALDH2 deficiency is associated with increased risk of depression, particularly with low-dose alcohol consumption (<15 g/day) 7.
Companion Genetic Factor
ADH1B polymorphisms also contribute to the flushing response 8. The ADH1B enzyme accelerates ethanol oxidation to acetaldehyde, and when combined with ALDH2 deficiency, this creates even greater acetaldehyde accumulation. Both ALDH2-rs671 and ADH1B-rs1229984 variants are strongly associated with alcohol flushing in East Asian populations 8, 9.
Clinical Recommendations
For patients with alcohol flushing:
- Strongly counsel complete alcohol abstinence given the markedly elevated cancer risk
- Emphasize that the flushing response is a protective warning sign, not something to "push through"
- Screen for concurrent tobacco use and counsel cessation
- Consider genetic testing for ALDH2 status in high-risk East Asian patients with heavy alcohol use
- Monitor for signs of aerodigestive tract cancers in those who continue drinking despite flushing
The flushing response should be recognized as a precision medicine opportunity for cancer prevention in this genetically defined high-risk population 5, 6.